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In the field of breast biology, there is a growing
appreciation for the ‘‘gatekeeping function’’ of basal
cells during development and disease processes yet
mechanisms regulating the generation of these cells
are poorly understood. Here, we report that the
proliferation of basal cells is controlled by SLIT/
ROBO1 signaling and that production of these cells
regulates outgrowth of mammary branches. We
identify the negative regulator TGF-b1 upstream of
Robo1 and show that it induces Robo1 expression
specifically in the basal layer, functioning together
with SLIT2 to restrict branch formation. Loss of
SLIT/ROBO1 signaling in this layer alone results in
precocious branching due to a surplus of basal cells.
SLIT2 limits basal cell proliferation by inhibiting
canonical WNT signaling, increasing the cytoplasmic
and membrane pools of b-catenin at the expense
of its nuclear pool. Together, our studies provide
mechanistic insight into how specification of basal
cell number influences branching morphogenesis.
INTRODUCTION
Like other glandular organs, the mammary gland (breast) con-
tains a bilayered epithelial structure consisting of an outer layer
of basal myoepithelial cells (MECs) encircling an inner layer of
luminal epithelial cells (LECs) (Silberstein, 2001). Historically,
the basal layer has been largely overlooked by researchers,
who focused instead on LECs, considered the origin of most
carcinomas. Recently, however, appreciation has grown for
the importance of this basal layer as an ‘‘epithelial gatekeeper,’’
generating the boundary between epithelial and stromal com-
partments, organizing tissue structure, maintaining stem cells,
and suppressing cancerous growth (Barsky and Karlin, 2006;
Gudjonsson et al., 2005). Nevertheless, the mechanisms regu-
lating the generation and proliferation of these cells are poorly
understood.
During postnatal mammary morphogenesis, highly mitotic
structures at the tips of growing ducts called ‘‘end buds’’ invade
the fatty stroma and establish the mammary tree. Cap cells,Develcomposing the basal layer of the end bud, differentiate into
MECs that fully ensheath the ducts (Williams and Daniel, 1983).
During pregnancy, however, the LECpopulation greatly expands
as alveoli develop, resulting in sparse MEC coverage as basal
cells stretch to accommodate the increased volume. This
discontinuous coverage of an expanding LEC population also
occurs during tumorigenesis when uncontrolled growth of
LECs breaks through the myoepithelial barrier, resulting in the
transition fromductal carcinoma in situ to infiltrating ductal carci-
noma. Thus, understanding the mechanisms that regulate basal
cell proliferation promises insight into basic developmental pro-
cesses such as tissue morphogenesis and disease processes
such as tumor metastasis.
Branching morphogenesis is a developmental program that
imparts functional complexity to many biological systems (An-
drew and Ewald, 2010). End bud bifurcation generates the
primary ductal architecture, but lateral outgrowth of secondary
and tertiary ducts is required to achieve full arborization of the
mammary tree (Silberstein, 2001). The branching pattern of the
mammary gland is stochastic, with the major requirement being
an open ductal architecture that allows pregnancy-induced alve-
olar infilling. Consequently, inhibitory signals are critical and
TGF-b1 is a key negative regulator of this process (Ewan et al.,
2002; Ingman and Robertson, 2008; Nelson et al., 2006). It func-
tions by inhibiting cellular proliferation, but how it restricts cell
growth, especially in a cell type-specific manner, is not well
defined. In LECs, noncanonical WNT5A acts downstream of
TGF-b1 (Pavlovich et al., 2011; Roarty and Serra, 2007) and
inhibits cell growth by antagonizing canonical WNT signaling
(Roarty et al., 2009). In cap cells or MECs, no downstreammedi-
ators of TGF-b1 have been identified to date.
SLITs are a conserved family of secreted proteins that were
originally discovered in the nervous system, where they signal
through ROBO receptors to mediate axonal guidance and
branching (Brose et al., 1999; Wang et al., 1999). Their guidance
function is well conserved and involved in directing migration of
many cell types, including neural crest, immune, and tumor cells
(Ypsilanti et al., 2010). In contrast, the branching function of
SLITs has been chiefly described in the vascular system (Jones
et al., 2008; Marlow et al., 2010) and seldom in epithelial organs
of vertebrate animals (Grieshammer et al., 2004), where instead
a distinct role for SLITs and ROBOs as tumor suppressors has
been identified (Dallol et al., 2005; Marlow et al., 2008; Prasad
et al., 2008; Yang et al., 2010). Thus, SLIT/ROBO signaling is
emerging as an important regulator of cellular interactions.opmental Cell 20, 827–840, June 14, 2011 ª2011 Elsevier Inc. 827
Developmental Cell
SLIT/ROBO1 Restricts Mammary Branch FormationIn the mammary gland during branching morphogenesis,
SLITs are expressed by both LECs and MECs, whereas expres-
sion of ROBO1 is restricted to just basal cap cells and MECs
(Strickland et al., 2006). In the current study, we investigate the
mechanism by which loss of Slits or Robo1 results in a preco-
cious branching phenotype characterized by an excess of disor-
ganized MECs. We identify the negative regulator, TGF-b1,
upstream of ROBO1 and show that it induces Robo1 specifically
in the basal layer, functioning together with SLIT2 to control
branch formation. We determine that basal cell number alone
influences branch number and demonstrate that SLIT/ROBO1
signaling limits branch formation by antagonizing canonical
WNT signaling and restricting basal cell proliferation.
RESULTS
ROBO1 Inhibits Branching Morphogenesis of Mammary
Epithelium
To investigate a role for SLIT/ROBO1 signaling in epithelial
branchingmorphogenesis, we examined theRobo1 loss-of-func-
tion phenotype by transplanting Robo1/ and wild-type (WT)
littermate epithelium into contralateral fat pads of immunocom-
promised (Foxn1nu) mice that were precleared of their endoge-
nous mammary epithelial buds prior to puberty (Strickland et al.,
2006). For this initial analysis, we used transplanted epithelium
to assess the outgrowth andbranching of epitheliawithout poten-
tial secondaryeffects of theRobo1/mutationand toensure that
both Robo1/ and WT tissues were subject to the same
hormonal environment. We observed that Robo1/ and WT
ducts grew to similar lengths, but that Robo1/ transplants dis-
played excessive side branching (Figure 1A). We quantified the
phenotype and found a >2-fold increase in secondary branches
and tertiary buds in Robo1/ transplants (Figure 1B) but no
significant difference in primary branch number (Figure 1C), indi-
cating that increased lateral bud formation, rather than excessive
end bud bifurcation, is responsible for the phenotype. We previ-
ously observed that transplanted knockout tissue contains a
hyperplastic phenotype (Marlow et al., 2008; Strickland et al.,
2006), and thereforewe quantified branching in intact, unmanipu-
latedRobo1/ glands. Intact glands are similarly hyperbranched
(H.M., unpublished data), but during this early stage of develop-
ment they do not display the hyperplastic changes associated
with transplanted tissue (see Figure S1A available online).
We also examined branching morphogenesis in an organo-
typic culture model generated from intact Robo1/ glands in
which aggregated cells (Figure 1D) or ductal fragments (Fig-
ure S1B) were grown in growth factor-reduced Matrigel (Ewald
et al., 2008; Holliday et al., 2009). Robo1/ organoids were
devoid of hyperplastic changes, such as luminal infilling, and
contained a bilayered epithelium (Figure 1D; Figure S1C). The
majority of Robo1/ organoids were branched, whereas WT
organoids were unbranched hollow structures (Figure 1E). The
few WT organoids containing branches had an average of three
branches, whereas Robo1/ organoids had twice as many
branches (Figure 1F). Fragment organoids generated from
Robo1/ tissue also recapitulated the hyperbranched pheno-
type (Figures S1B and S1D). Together, these data demonstrate
that under the same conditions, Robo1/ epithelium generates
more branches than WT epithelium.828 Developmental Cell 20, 827–840, June 14, 2011 ª2011 Elsevier ISLIT2 Is the ROBO1 Ligand that Inhibits Mammary
Branching
SLITs are ligands for ROBO1, and previous studies have shown
that Slit2 and Slit3, but not Slit1, are expressed in the mammary
gland (Strickland et al., 2006). To evaluate whether combined
loss of Slit2 and Slit3 phenocopies the Robo1/ hyperbranch-
ing defect, we transplanted Slit2/;Slit3/ epithelium into
precleared fat pads of Foxn1nu mice. Loss of Slits, similar to
loss of Robo1, led to a significant increase in secondary
branches and tertiary buds but no difference in primary duct
number (Figures 2A and 2B).
Next, we examined whether exogenous SLIT inhibits branch
formation. We implanted, at the forefront of WT mammary trees,
Elvax slow-release pellets containing either recombinant SLIT2,
observed by immunohistochemistry in a 5 mm radius around the
pellet (H.M., unpublished data), or control BSA (Figure 2C). Elvax
is a biologically compatible polymer that is used to deliver mole-
cules, including functionally inert BSA (Silberstein and Daniel,
1987). SLIT2, rather than SLIT3, was implanted because it is
highly expressed during branching morphogenesis (Strickland
et al., 2006). After 7 days, secondary branching was suppressed
in regions near SLIT2 pellets (Figure 2C, right, box), with the few
branches in proximity containing small lateral buds, which
frequently turned away from SLIT2 (Figure 2C, arrow). The
distance between secondary branches, located within 5 mm of
the pellets, was significantly longer in regions surrounding
SLIT2 pellets (Figure 2D). There was also a preference for growth
away from SLIT2, and this was quantified by counting the
secondary branches extending toward (ipsilateral) or away
from (contralateral) the pellets (Figure 2E). These data show
that SLIT2 inhibits lateral branch formation but not the growth
of primary ducts past the pellet.
We also examined the effects of SLIT2 on organoid branching.
BecauseWT organoids are largely unbranched in the absence of
growth factors (Figures 1D–1F), we induced branching by adding
hepatocyte growth factor (HGF), and then challenged the
cultures with SLIT2. There was an 80% reduction in the number
of WT branched organoids, a reduction that did not occur with
Robo1/ organoids (Figures 2F–2H). Together, these studies
strongly support the idea that SLIT2 and ROBO1 function in a
ligand/receptor relationship to regulate lateral branching during
mammary morphogenesis.ROBO1 Is a Downstream Effector of TGF-b1
in Myoepithelial Cells
TGF-b1 is a key negative regulator of mammary ductal develop-
ment and branching morphogenesis. One explanation for our
data is that SLIT/ROBO1 signaling is downstream of TGF-b1
and, indeed, transcriptional profiling experiments identified
Robo1 as a TGF-b1-upregulated transcript inmammary cell lines
(Labbe et al., 2007). To investigate the biological significance of
this result, we cultured primary mammary epithelial cells (ECs)
with TGF-b1 along with inhibitors of both protein synthesis
(cycloheximide) and the TGF-b1 receptor type 1 (SB431542).
We found a TGF-b1-induced, 2-fold increase in Robo1
mRNA and protein, with the change in mRNA prevented by the
presence of either inhibitor (Figures 3A and 3B), suggesting
that TGF-b1 signaling upregulates ROBO1 via a noncanonicalnc.
Figure 1. Loss of Robo1 in Mammary Epithelium Leads to Excess Branching Morphogenesis
(A) Contralaterally transplanted, hematoxylin-stained, virgin WT and Robo1/ outgrowths. Insets represent magnified images.
(B and C) Branchpoint analysis (n = 5 animals).
(D) Representative images of WT and Robo1/ organoids obtained with phase contrast (left) and immunofluorescence using CK-14 (MECs) and E-cadherin
(LECs) (right).
(E) Quantification of total branched Robo1/ and WT organoids (n = 4 experiments, >300 organoids/genotype).
(F) Quantification of branches per Robo1/ and WT organoid (n = 3 experiments, >300 organoids/genotype).
Scale bars represent 3 mm (A) and 30 mm (D). Asterisks indicate significance in a Student’s t test (NS, not significant).
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protein synthesis (Yue and Mulder, 2001).
We previously showed thatRobo1 is specifically expressed on
cap cells and MECs during branching morphogenesis (Strick-
land et al., 2006). To assess whether this pattern is recapitulated
in organoids, we assayed for b-galactosidase (b-gal) activity,
taking advantage of lacZ inserted downstream of the Robo1
promoter (Figures 3C–3E) (Long et al., 2004). As predicted by
Robo1 expression in vivo, we observed positive b-gal stainingDevelon the surface of organoids that coimmunostained with an
MEC marker (Figure 3C). In a typical Robo1/ organoid,
30% of MECs stain positive for b-gal, and we considered this
the threshold for positivity. Organoids were treated with
TGF-b1 for 24 hr, resulting in significantly more b-gal-positive
organoids (Figures 3D and 3E). To investigate whether this
ROBO1 upregulation contributes to branch inhibition, we used
HGF to elicit branching of WT organoids, followed by treatment
with TGF-b1, SLIT2, or both (Figure 3F). TGF-b1 or SLIT2opmental Cell 20, 827–840, June 14, 2011 ª2011 Elsevier Inc. 829
Figure 2. Loss of Slit2 Results in Excess Branching; Conversely, Exogenous SLIT2 Treatment Results in Decreased Branching
(A) Contralaterally transplanted, hematoxylin-stained, virgin WT and Slit2/;Slit3/ outgrowths.
(B) Branchpoint analysis (n = 10 animals).
(C) Representative whole-mount images of carmine-stained glands contralaterally implantedwith Elvax pellets containing either BSA or SLIT2. Black dashed lines
outline pellets, white dashed boxes highlight areas near pellets, and the arrow points to an end bud turning away from SLIT2.
(D) Quantification of the distance between 2 branches (5 mm radius; n = 5 animals).
(E) Quantification of 2 branches ipsilateral or contralateral to the pellet (n = 5 animals).
(F) Representative phase-contrast images of WT or control Robo1/ organoids induced to branch with HGF. After 24 hr, organoids were treated with HGF either
alone or with SLIT2 and allowed to grow for 6 days.
(G and H) Quantification of the number of WT and Robo1/ organoids in each condition that had three or more branches (n = 3 experiments, >100 organoids/
treatment).
Scale bars represent 1 mm (A and C) and 75 mm (F). Asterisks indicate significance in a Student’s t test (NS, not significant).
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Figure 3. TGF-b1 Upregulates Robo1, Leading to Enhanced Branch Inhibition in Response to SLIT2
(A) Robo1 levels after treatment with TGF-b1 alone or in combination with SB431542 or cycloheximide. Relative RT-qPCR analysis of ECs harvested from virgin
mice (n = 3 independent RNA sets).
(B) ROBO1 protein levels after TGF-b1 treatment. Positive control is COS-7 cells expressing pSecTagBRobo1myc.
(C) Representative images of Robo1/ organoids stained for b-gal (blue) (left) with a magnified image showing b-gal (upper) and coimmunostaining with
CK-14 (green), E-cadherin (red), and nuclear marker Hoechst (blue) (lower).
(D and E) Representative phase-contrast images of b-gal-stained Robo1/ organoids after mock or TGF-b1 treatment. The percentage of organoids
containingR30% positive cells was quantified (n = 3 experiments, 100 organoids/treatment).
(F and G) WT and Robo1/ organoids were stimulated to branch with HGF, treated with SLIT2, TGF-b1, or both, and imaged using bright-field microscopy
(n = 3 experiments, >200 organoids/treatment).
(H and I) Quantification of WT and Robo1/ organoids in each condition that had three or more branches (n = 3 experiments, >100 organoids/treatment).
Scale bars represent 30 mm (C, D, F, and G). Asterisks indicate significance in a Student’s t test (E) or ANOVA (A and H) (NS, not significant).
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Figure 4. SLIT2/ROBO1 Signaling Inhibits the Proliferation of Basal Cap/Myoepithelial Cells
(A) Quantification of percentage of proliferating (EdU+) cells in 2D organoids (n = 3 experiments, >500 cells).
(B–E) RT-qPCR andwestern blot analysis ofCyclin D1 andCyclin D1 levels, respectively, inWT andRobo1/MECs and LECs (RT-qPCR: n = 3 independent RNA
sets; western blot: n = 3 experiments).
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SLIT/ROBO1 Restricts Mammary Branch Formationinhibited branching to a similar degree, but the effect was signif-
icantly enhanced upon treatment with both TGF-b1 and SLIT2
(Figures 3F and 3H). Moreover, Robo1/ tissue was refractory
to TGF-b1 treatment (Figures 3G and 3I), as it was to SLIT2 treat-
ment (Figures 2F and 2H). These data support the notion that up-
regulation of ROBO1 in basal cells by TGF-b1 restricts branching
by enhancing the inhibitory effects of SLIT.
SLIT/ROBO1 Signaling Regulates Basal Cell
Proliferation
TGF-b1 inhibits mammary branching morphogenesis by re-
ducing overall cellular proliferation (Ewan et al., 2002). To inves-
tigate whether SLIT/ROBO1 signaling similarly inhibits cell
proliferation, but specifically in basal cells, we generated ductal
fragments from WT glands and cultured them as 2D, bilayered,
circular organoids (Figure S2A). SLIT2 treatment resulted in an
50% reduction in MEC proliferation (Figure 4A; Figure S2B),
similar to the reduction observed in a human MEC line, HME50
(Figures S2C and S2D), with no change in LEC proliferation (Fig-
ure 4A). These results suggest that only MECs are regulated by
SLIT/ROBO1 signaling, consistent with the restricted expression
of ROBO1 on these cells. However, LECs had a low basal index
of proliferation, perhaps due to contact inhibition in the organoid
center. To address this possibility, we separated WT and
Robo1/ MECs from LECs using differential trypsinization
(Figures S2E–S2H) (Darcy et al., 2000), and examined a regulator
of cell-cycle entry, Cyclin D1. There was a significant increase in
Cyclin D1 by RT-quantitative PCR (Figure 4B) and western blot
(Figure 4D) in Robo1/ MEC-enriched fractions, whereas no
differences between genotypes were observed in LEC-enriched
fractions (Figures 4C and 4E).
We also assessed cell proliferation in vivo in mammary glands
by intraperitoneal injections of 5-ethynyl-20-deoxyuridine (EdU)
(Figure 4F). We initially focused on the mitotically active end
buds and found an 2-fold increase in cap cell proliferation in
Robo1/ glands and no significant change in LEC proliferation
(Figures 4G and 4H), consistent with our data obtained in cell
culture (Figures 4A–4E). Cap cell proliferation was also evaluated
in glands containing SLIT2 and BSA Elvax pellets (Figures 4I
and 4J), and a concordant 2-fold decrease in cap cell prolifer-
ation was observed in end buds near SLIT2 pellets with, again,
no significant difference in LEC proliferation.
We also examined subtending ducts to evaluate the conse-
quences of having surplus cap cells, which differentiate into
MECs. In agreement with previous studies (Bresciani, 1968),
we found very few proliferating basal cells alongWT orRobo1/
ducts, suggesting that, unlike cap cells, differentiated MECs are
refractory to the proproliferative consequences of losing SLIT/
ROBO1 signaling (H.M., unpublished data). Evaluation of ductal
morphology, however, revealed an overabundance of MECs in
Robo1/ ducts, suggesting that the consequence of exuberant(F–H) Individual channel images of Hoechst-stained, EdU-labeled, p63-immunos
(I and J) Quantification of MEC and LEC EdU+ nuclei in WT glands surrounding S
(K) Individual and merged channel images of p63-immunostained and Hoechst-s
(L) Quantification of MECs in Robo1/ and WT ducts (n = 3 animals).
(M) Quantification of the distance between MECs in Robo1/ and WT ducts (n
(N) FACS analysis of the relative level of basal (LinCD24+CD29hi) to total (LinC
Scale bars represent 20 mm (F and K). Asterisks indicate significance in a Studen
Develcap cell proliferation is excess MECs (Figure 4K). We quantified
both the number of MECs and the distance between them, and
found that Robo1/ glands have significantly more cells that
are closer together (Figures 4L and 4M). We also used fluores-
cence-activated cell sorting (FACS) to examine the relative levels
of basal cells in WT and Robo/ glands and found a >2-fold
increase in basal cells (LinCD24+CD29hi) in Robo1/ tissue
(Figure 4N). Together, these data show that SLIT2/ROBO1
signaling constrains cap cell proliferation, and that in its absence
there is an excess of disorganized MECs.
The Number of Basal Cells Positively Influences
the Number of Branches
These studies raise the question as to whether basal cell number
alone influences branching. To investigate, we analyzed organo-
ids (100 mm diameter) that were either unbranched or con-
tained one bud or branch. We observed MECs congregating at
these bud/branch sites, with formation of a single bud/branch
correlating with increased MEC number (Figures 5A and 5B;
Figure S3A). To evaluate the consequences of MEC localization
on bud growth, we generated and labeled WT organoids with
EdU, and again analyzed similarly sized organoids containing
a single bud (Figures 5C and 5D). Quantification of EdU+ cells
in each quadrant revealed that bud-containing quadrants had
2-fold more EdU+ cells (Figure 5E). Previous studies have
shown that fibroblastic growth factor 2 (FGF2) is secreted from
MECs and positively regulates mammary branching (Gomm
et al., 1997). We evaluated FGF2 levels in WT and Robo1/
MECs and, while both populations express FGF2, Robo1/
cells express significantly higher levels (Figure 5F).
Our data suggest that MEC number regulates mammary
branching by supplying growth factors. To address this role for
MECs, we performed mixing experiments in which we manipu-
lated the ratio of MECs to LECs. First, we ensured that organoids
in these assays arose from cell aggregates, rather than a single
stem/progenitor cell, by mixing MECs from b-actin-EGFP mice
with unlabeled LECs and documenting the formation of mixed-
labeled organoids (Figure S3B). Next, we removed HGF from
the culture media and manipulated the proportion of MECs to
LECs, generating organoids that contained either a normal
(1:3) or high (3:1) ratio of cells (Darcy et al., 2000). These ratios
were confirmed by immunoblotting the input mixtures with MEC
(CK-14) or LEC (E-cadherin) markers (Figure 5G). After 7 days,
we categorized them as either branched or unbranched (Fig-
ure 5H), and quantified the number in each category (Figure 5I).
A high ratio of MECs to LECs produced significantly more
branched structures compared to a low ratio, which produced
more unbranched structures, consistent with basal cell number
having a corresponding influence on branch number (Figures
1, 2, and 4). Together, these data support a model in which
SLIT/ROBO1 restricts the number of MECs by limiting cap celltained WT and Robo1/ end buds (n = 3 animals).
LIT2 and BSA pellets (5 mm radius) (Figure 2C) (n = 3 animals).
tained WT and Robo1/ ducts.
= 3 animals).
D24+) epithelial cells in Robo1/ and WT littermate glands.
t’s t test (NS, not significant).
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Figure 5. Basal Cell Number Influences Organoid Branching State
(A) Merged channel images of unbranched, budded, or branched WT organoids stained with Hoechst, phalloidin, and MEC marker p63.
(B) Quantification of organoid diameter and MEC number in budded, branched, and unbranched organoids (n = 3 experiments, >50 organoids/branching state).
(C) Cartoon model of an EdU-labeled organoid divided into quadrants with a bud containing a quadrant designated Q1.
(D and E) Quantification of quadrants from organoids labeled with EdU (red) and Hoechst (blue) (n = 3 experiments, >50 organoids/quadrant).
(F) Relative RT-qPCR analysis of FGF2 levels in MECs harvested from WT and Robo1/ glands (n = 3 independent RNA sets).
(G) Representative immunoblots from lysates of input cells at different MEC and LEC ratios: MEC marker, CK-14; LEC marker, E-cadherin; loading control,
tubulin.
(H) Representative images of 1MEC:3LEC and 3MEC:1LEC organoids obtained with phase contrast (left) and immunofluorescence using p63 and phalloidin
(right).
(I) Quantification of branched 3MEC:1LEC versus 1MEC:3LEC organoids (n = 3 experiments, >300 organoids/population).
Scale bars represent 30 mm (A, D, and H). Asterisks indicate significance in a Student’s t test (NS, not significant).
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SLIT/ROBO1 Restricts Mammary Branch Formationproliferation. In the absence of SLIT/ROBO1 signaling, a surplus
of MECs is generated that positively regulates branching by
providing growth factors, such as FGF2.
SLIT/ROBO1 Signaling Regulates the Subcellular
Localization of b-Catenin
Overexpression of activated b-catenin in the basal compartment
of the mammary gland results in excess proliferation and hyper-
branching (Teuliere et al., 2005), similar to the phenotype
described in this study. It also produces basal-type hyperplasias
similar to, but more severe than, phenotypes observed at later
stages of development in Robo1/ and Slit2/;Slit3/
outgrowths (Marlow et al., 2008) (Figures 1A and 2A). To investi-
gate whether b-catenin is downstream of SLIT/ROBO1 in basal
cells, we treated HME50 cells with SLIT2 and, using biochemical
fractionation, detected a shift in b-catenin from the nuclear to the
cytosolic/membrane fractions (Figure 6A). We confirmed this
change in subcellular localization of b-catenin with immunocyto-
chemistry. Figure 6B shows that SLIT2 treatment enhances the
staining of b-catenin and E-cadherin at the membrane, with no
change in the levels of total protein as assayed by immunoblot
(Figure 6C). b-catenin was also activated in these cells using
lithium chloride (LiCl) following SLIT2 treatment and, again, there
was increased b-catenin membrane staining in SLIT2-treated
samples and significantly decreased nuclear translocation (Fig-
ure S4A). Together, these studies suggest that SLIT/ROBO1
signaling influences b-catenin’s subcellular localization. In
cancer cells, this occurs through the Akt/PKB pathway (Prasad
et al., 2008; Tseng et al., 2010), which negatively regulates
glycogen synthase kinase 3-beta (GSK-3b) downstream of
growth factor receptors (Cross et al., 1995). Similarly, we found
that EGF and insulin (GF) treatment of primary MECs and
LECs, as well as HME50 cells, increased the phosphorylation
of Akt and GSK-3b (Figure 6D; Figure S4B). Pretreatment of cells
with SLIT decreased this response in MECs and HME50 cells,
but not in LECs. Decreased phosphorylation of GSK-3b acti-
vates it (Cross et al., 1995), favoring the accumulation of b-cate-
nin in the cytosol and membrane of these cells (Figures 6A–6C).
Next, we probed whole MEC lysates with an antibody directed
against active b-catenin (ABC) (Staal et al., 2002) and observed
a decrease in this form upon SLIT2 treatment (Figure 6E). We
used this antibody to examine the basal layer of WT organoids.
In untreated organoids, there is modest positive staining in the
nucleus. Treating cells with an activator of canonical WNT
signaling dramatically increased the nuclear staining of unphos-
phorylated b-catenin, whereas treatment with SLIT2 reduced
b-catenin’s nuclear stainingwhile increasing itsmembrane stain-
ing (Figure 6F). These data indicate that SLIT2 inhibits nuclear
translocation of b-catenin, likely decreasing its transcriptional
functions. To investigate, we evaluated LEF/TCF transcriptional
targets by RT-qPCR and found increased expression of Axin2,
Cyclin D1, and Tcf1 mRNA in primary MECs harvested from
Robo1/ glands, and a concordant decrease in mRNA from
WT MECs treated with SLIT2 (Figure 6G). One of these tran-
scripts can also be monitored in vivo using Axin2lacZ/+ mice.
These mice faithfully reflect b-catenin signaling by reporting
Axin2 expression in multiple tissues (Lustig et al., 2002). During
branching morphogenesis, there is robust b-gal staining in cap
cells of the end bud and basal MECs of subtending ducts (Fig-Develure S4C) (Zeng and Nusse, 2010). We implanted SLIT2 and
BSA pellets into Axin2lacZ/+ glands and observed significantly
reduced b-gal staining in MECs with SLIT2 but not BSA (Fig-
ure 6H). These data indicate that SLIT2 inhibits the proliferation
of ROBO1-expressing basal cells by opposing the activation of
b-catenin. Taken together, our data suggest a mechanism for
restricting mammary branching morphogenesis by controlling
cell number, specifically in the basal layer of the bilayered
mammary gland (Figure 7).
DISCUSSION
Our studies define a mechanism governing mammary branching
morphogenesis whereby SLIT/ROBO1 signaling inhibits lateral
branch formation by controlling the proliferation of the basal
cell layer. Specificity of signaling is achieved by restricting the
expression of ROBO1 to the basal layer and regulating it with
TGF-b1. This mechanism of SLIT regulating branching is
different from the mechanisms identified in the nervous system,
where an extracellular source of SLIT signals to ROBO receptors
expressed on growth cones or axon shafts, resulting in cytoskel-
etal reorganization that leads to growth cone bifurcation or
lateral extension of membrane away from the axonal shaft (Ypsi-
lanti et al., 2010). In contrast, in the vasculature, a mechanism
has been identified that is potentially similar to the one observed
in the mammary gland. Here, SLIT is expressed by pericytes and
signals through endothelial ROBO4 receptor to restrain sprout-
ing angiogenesis by downregulating pathways activated by
VEGF/VEGFR (Jones et al., 2008, 2009). VEGF increases the
nuclear localization of b-catenin in endothelial cells (Ilan et al.,
2003). If this drives sprouting angiogenesis, then SLIT/ROBO4
signaling could inhibit this process by sequestering b-catenin
in the cytoplasm, similar to the effects observed in the mammary
gland (Figure 6). Thus, the mechanism of SLIT/ROBO action in
the mammary gland, via restricting b-catenin-dependent cell
proliferation, may apply to vessel sprouting as well.
These studies highlight the importance of MECs as key
regulators of breast development. MECs are responsible for
producing components of the basal lamina and mediating inter-
actions between ductal LECs and the extracellular environment.
During development, they synthesize and secrete many key
growth factors, including WNTs and FGFs (Figure 5F) (Gomm
et al., 1997; Kouros-Mehr andWerb, 2006), which act as branch-
ing factors during morphogenesis (Lindvall et al., 2006; Lu et al.,
2008). FGF does not promote MEC proliferation directly, but
instead functions in a paracrine fashion to induce LEC prolifera-
tion (Figures 5C–5F) (Gomm et al., 1997). This distinction
between basal and luminal cells, however, may not exist in the
end bud. Instead, in this context, loss of FGF receptor 2 in a
subset of cells leads to decreased proliferation of cap and
luminal body cells (Lu et al., 2008), in addition to a hypobranching
phenotype that highlights the positive contribution of cell prolif-
eration in the end bud to branch formation (Lu et al., 2008; Parsa
et al., 2008). Changes in branching are also observed upon
constitutive activation of canonical WNT signaling, as demon-
strated by overexpression of an N-terminally truncated, acti-
vated form of b-catenin in the basal cell layer that results in
excess basal cells and precocious lateral bud formation (Teuliere
et al., 2005). Furthermore, the opposite phenotype, feweropmental Cell 20, 827–840, June 14, 2011 ª2011 Elsevier Inc. 835
Figure 6. SLIT/ROBO1 Signaling Regulates the Subcellular Localization of b-Catenin
(A) Biochemical fractionation of HME50 cells treated with SLIT2. Top: representative immunoblots for b-catenin; nuclear loading control, histone H1; cytoplasmic
loading control, GAPDH; membrane loading control, cadherin. Bottom: quantitative analysis of b-catenin (n = 3 experiments).
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Figure 7. The SLIT/ROBO1 Signaling Axis Regulates Mammary
Gland Branching Morphogenesis
Cartoon model of how the mammary basal layer promotes branching
morphogenesis, and how this effect is countered by SLIT/ROBO1 signaling.
From left to right, TGF-b1 elevates the expression of Robo1 in basal cells.
ROBO1 then interacts with ligand SLIT2 to inhibit the nuclear accumulation of
b-catenin by inhibiting Akt activation. Inhibiting Akt results in un-
phosphorylated, activated GSK-3b, which phosphorylates b-catenin and
favors its degradation or accumulation at themembrane (not pictured), thereby
inhibiting its translocation to the nucleus and subsequent activation of tran-
scription. Thus, by curbing basal cell proliferation, SLIT/ROBO1 signaling
inhibits mammary gland branching morphogenesis.
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gous for the Lrp6 WNT receptor that also display reduced levels
of b-catenin activation (Lindvall et al., 2009). Together, these
studies highlight the importance of growth factor production by
basal cells in enhancing branch formation.
We discovered that excessive mammary branching also
occurs in the absence of SLIT/ROBO1 signaling due to both
a surplus of basal cells, which provides high levels of growth
factors, especially FGF2 (Figure 5F), and increased activation
of canonical WNT signaling, due to aberrant localization of b-cat-
enin (Figure 6). Taken together, our findings delineate an arm of
the TGF-b1 pathway that restrains branching by negatively regu-
lating progrowth signals in basal cells through two mechanisms:
(1) directly, by inhibiting the activation of WNT signaling (Fig-
ure 6); and (2) indirectly, by limiting basal cell number and,
consequently, the supply of positive factors (Figure 5). Without
this growth control in the basal compartment, the mammary
gland generates an overabundance of MECs, which produce(B) Merged channel images of Hoechst-, b-catenin- (top) or E-cadherin- (bottom)
intensities over 5 mm of the highest-staining membrane (n = 3 experiments, >50
(C) Representative immunoblots and quantification of E-cadherin and b-catenin
(D) Representative immunoblots and quantification for p-Akt (left) and p-GSK-3b
factors (total Akt and GSK-3b as loading controls) (n = 2 experiments).
(E) Representative immunoblots and quantification for activated b-catenin (to
(n = 2 experiments).
(F) Individual and merged channel images of 6-day-old organoids stained with p
lines highlight nuclear area. Nuclear ABC levels were recorded as mean pixel int
(G) Relative RT-qPCR analysis of b-catenin target genesAxin2,Cyclin D1, and Tcf1
WT MECs (bottom) (n = 3 independent RNA sets).
(H) b-gal staining of Axin2lacZ/+ mammary tissue in regions near SLIT2 (right) an
bottom panels aremagnified images of highlighted (red boxes) ductal area. Percen
pellet (n = 3 experiments).
Scale bars represent 10 mm (B and F) and 0.5 mm (H). Asterisks indicate signific
Develan excess of growth factors that promote branching. These
surplus MECs eventually invade the luminal population, creating
a disruption in cell adhesion (Strickland et al., 2006). Moreover,
over time, these excess growth factors, along with other
changes that occur such as upregulation of CXCR4 and SDF1,
spur the development of hyperplastic lesions with basal charac-
teristics (Marlow et al., 2008). Thus, the loss of growth control in
the basal compartment, identified in the current study, may
provide the fundamental defect that is the basis for other disrup-
tions occurring in mature and transplanted tissue in the absence
of SLIT/ROBO1 signaling.
Our studies elucidate a newweb of signaling that links TGF-b1
to the control of b-catenin through the SLIT/ROBO1 pathway.
There is abundant research identifying roles for bothWNT/b-cat-
enin and TGF-b signaling pathways in tissue morphogenesis as
regulators of cell proliferation, migration, and differentiation.
That these pathways are directly connected is illustrated in the
process of epithelial-to-mesenchymal transition (EMT) in which
TGF-b1 induces the dissociation of b-catenin from cell contacts
and promotes its subsequent translocation into the nucleus to
drive transcription of LEF/TCF targets (Masszi et al., 2004; Med-
ici et al., 2006). There is little evidence, however, that the reverse
happens, with TGF-b1 supporting cell adhesion by increasing
the association of b-catenin with cadherin. Our studies provide
evidence that this occurs in a developmental context, and that
by upregulating Robo1, TGF-b1 indirectly supports a mesen-
chymal-to-epithelial transition (MET) in which cap cells differen-
tiate into MECs. This functional role for SLIT during MET is
supported by studies in cancer cell lines where knockdown of
SLIT, for example in a non-small-cell lung cancer line, activates
Akt and inhibits GSK-3b. This, in turn, increases the levels of
nuclear b-catenin and increases the expression of Snail, a crucial
regulator of EMT/MET, resulting in decreased cadherin expres-
sion and increased cell migration (Tseng et al., 2010). Concor-
dantly, in a study of breast cancer cells, SLIT overexpression
inhibits Akt, activating GSK-3b, resulting in reduced nuclear
accumulation of b-catenin and increased cadherin/b-catenin at
the cell membrane (Prasad et al., 2008). Additionally, SLIT/
ROBO1 signaling could regulate b-catenin directly through its
inhibitory effect on Akt, which phosphorylates b-catenin on
Ser552 and increases its nuclear translocation and activation
of canonical WNT target genes (He et al., 2007). Thus, the ability
of SLITs to function as tumor suppressors lies in their capacity to
curb both cell motility and cell proliferation. Here we providestained HME50 cells. Plasma membrane signals were recorded as mean pixel
cells/treatment).
after SLIT2 treatment of HME50 cells (n = 3 experiments).
(right) in HME50 cells treated with SLIT2 alone or in combination with growth
p) in MECs treated with SLIT2 (total b-catenin [bottom] as loading control)
63, ABC, and Hoechst after mock, WNT3A, or SLIT2 treatment. White dashed
ensities of 252 mm of nuclear area (n = 3 experiments, >50 cells/treatment).
inWT compared toRobo1/MECs (top), andWT compared to SLIT2-treated
d BSA (left) Elvax pellets. Top panels reveal ductal proximity to Elvax pellets;
tage of b-gal-positiveMECs (CK14+) was quantified in ducts within 5mmof the
ance in a Student’s t test (NS, not significant).
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a suppressor of tumor cell growth by showing its function in
opposing canonical WNT signaling and limiting basal cell prolif-
eration during mammary branching morphogenesis.
Recently, the basal cell population has been shown to contain
a subpopulation of mammary stem cells (MaSCs) (Shackleton
et al., 2006; Stingl et al., 2006) whose regenerative capacity is
regulated by canonical WNT signaling (Badders et al., 2009;
Zeng and Nusse, 2010). Because MaSCs have the potential to
generate the repertoire and number of new cells necessary for
branching, it is tempting to speculate that they are required for
branch formation. Alternatively, it is possible that bipotent
progenitor cells, which may not have a basal phenotype, are
the operative cell type. In either case, it raises the possibility
that SLIT affects branching by regulating the production of
stem/progenitor cells. Indeed, recent data show that proges-
terone, which is responsible for side branching, initiates a series
of events whereby LECs spur the proliferation of MaSCs by
providing growth factors such as WNT4 and RANKL (Asselin-
Labat et al., 2010; Joshi et al., 2010). Branching was not evalu-
ated in these studies, and currently there is no evidence that
MaSCs contribute directly to branching, but our studies have
not excluded an effect of SLIT in countering the effects of
progesterone and restricting the proliferation of MaSCs.
In conclusion, this report shows that SLIT/ROBO1 signaling
is a central agent within a pathway that controls branching
morphogenesis. Our studies provide mechanistic insight into
how ROBO1 levels are influenced by a negative regulator,
TGF-b1, and how this, in turn, curtails basal cell production by
regulating the subcellular localization of b-catenin and inhibiting
canonical WNT signaling. We propose that specification of basal
cell number is a critical component regulating branch formation,
with SLIT/ROBO1 acting to check growth factor signaling by
curbing basal cell proliferation.EXPERIMENTAL PROCEDURES
Animals
The study conformed to guidelines set by the University of California, Santa
Cruz animal care committee (IACUC).MouseSlit2,Slit3,Robo1, andAxin2lacZ/+
knockouts were generated and genotyped as described (Lustig et al., 2002;
Strickland et al., 2006). The promoters for Robo1 and Axin2 drive the expres-
sion of lacZ and was assessed by b-gal staining (Strickland et al., 2006).Mammary Fat Pad Clearing, Transplantation, and Branching
Analysis
Mammary anlage were rescued from knockout embryos and transplanted into
precleared fat pads of Foxn1nu mice (Strickland et al., 2006). Contralateral
outgrowths were harvested 4 weeks posttransplant and subjected to whole-
mount hematoxylin staining. Primary branches were defined as ducts extend-
ing from the nipple and terminating in an end bud. Secondary and tertiary
branches were defined as bifurcating from primary ducts or secondary
branches, respectively.Primary Mouse Mammary Epithelial Cell Culture
Glandswere digested with collagenase and dispase (Figures S2E–S2H) (Darcy
et al., 2000). Differential trypsinization was performed to obtain purified MEC
and LEC fractions (Darcy et al., 2000). For mammary cell sorting, single-cell
suspensions from thoracic and inguinal mammary glands were prepared as
previously described (Shackleton et al., 2006). FACS analysis was performed
using a FACSAria (Becton Dickinson).838 Developmental Cell 20, 827–840, June 14, 2011 ª2011 Elsevier IRNA Extraction and RT-PCR Analysis
RNA was extracted using a PureLink RNA Mini kit (Invitrogen). cDNA was
prepared using an iScript cDNA synthesis kit (Bio-Rad). PCR was performed
in triplicate and quantified using a Rotor Gene 6000 real-time PCR machine
and software (Corbett Research) to assay SYBR green fluorescence (Bio-
Rad) (Livak and Schmittgen, 2001). Results were normalized to that ofGAPDH.
In Vitro Branching Morphogenesis Assays
Three-dimensional primary cultures were generated as previously described
(Lee et al., 2007). Briefly, to generate organoids, we embedded 10,000 ECs
in 100 ml of growth factor-reduced Matrigel (BD Biosciences)/0.7 cm2. Frag-
ment organoids were obtained by embedding purified epithelial fragments
into Matrigel (Ewald et al., 2008), and stimulated with 2.5 nM bFGF (Sigma).
Elvax Slow-Release Pellet Preparation and Surgical Implantation
Elvax pellets containing 271 ng of SLIT2 and 0.45mg of BSA or only 0.45 mg of
BSA (control) were contralaterally implanted at the forefront of the growing
ductal tree in wild-type CD1 mice and harvested after 7 days (Silberstein
and Daniel, 1987).
Antibodies, Reagents, and Cell Lines
Antibodies used were as follows: CK-14 (Covance); E-cadherin (R&D
Systems); p63 (Santa Cruz Biotechnology); ROBO1 (Abcam); Myc (9E10);
tubulin (Sigma); GAPDH (Santa Cruz Biotechnology); b-catenin (610154) (BD
Biosciences); ABC (8E7) (Millipore); histone H1 (Santa Cruz Biotechnology);
and Akt, p-Akt (Thr308), GSK-3b, and p-GSK-3b (Ser9) (Cell Signaling).
Nonantibody markers used were: Alexa Fluor 546 phalloidin for filamentous
actin (Invitrogen), Hoechst (Invitrogen) for nuclei, and EdU (Invitrogen) to label
proliferating cells. HME50 cells were cultured in DMEM-F12 supplemented
with 1003 mammary epithelial cell growth supplement (Cascade Biologics).
Western Blot and Cellular Fractionation
Tissue protein lysates were prepared and analyzed by western blot as
described (Marlow et al., 2008). For cellular fractionation, HME50 cells were
treated with SLIT2 for 4 hr and then fractionated using the Qproteome Cell
Compartment kit (QIAGEN).
Proliferation Assays
In vitro cultures were treated with 10 mM EdU for 1 hr before detection. In vivo
labeling was accomplished by intraperitoneal injections of EdU (25 ng/g of
body weight) followed by harvest 2 hr postinjection. Samples were subjected
to Click-iT chemistry (Invitrogen).
Statistical Analysis
Statistical tests and p values are indicated in the figure legends. Graph
columns represent the mean and error bars represent the standard error of
the mean.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and can be found with this
article online at doi:10.1016/j.devcel.2011.05.012.
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